PER 5.00% 10.5¢ percheron therapeutics limited

News: ANP Antisense Therapeutics Submits Clinical Trial Application For Atl1102 Phase Iib Dmd Trial..., page-2

  1. 1,031 Posts.
    lightbulb Created with Sketch. 104
    Deafining silence.............
    Noone got anything to say?
 
watchlist Created with Sketch. Add PER (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.